Clinical Gastroenterology and Hepatology
@aga-cgh.bsky.social
🤖GEMA-AI made more accurate predictions of waiting list outcomes than the currently available models, and could alleviate gender disparities for accessing LT.
Read more here➡️:https://ow.ly/15s550XjGH7
Read more here➡️:https://ow.ly/15s550XjGH7
October 29, 2025 at 12:53 PM
🤖GEMA-AI made more accurate predictions of waiting list outcomes than the currently available models, and could alleviate gender disparities for accessing LT.
Read more here➡️:https://ow.ly/15s550XjGH7
Read more here➡️:https://ow.ly/15s550XjGH7
🗣️Compared with non-IBD elderly, patients with #EO-IBD have similar risks for death and complications. Compared with AO-IBD, patients with EO-IBD are at higher risk for abdominal surgery, but not for perianal surgery. Read more here🔗: ow.ly/I0qt50XbJ0l
October 15, 2025 at 12:51 PM
🗣️Compared with non-IBD elderly, patients with #EO-IBD have similar risks for death and complications. Compared with AO-IBD, patients with EO-IBD are at higher risk for abdominal surgery, but not for perianal surgery. Read more here🔗: ow.ly/I0qt50XbJ0l
🔎Around 1 in 4 people with CCA have chronic liver diseases, and 1 in 10 have cirrhosis.
Read more here: ❇️ ow.ly/GIh450X2qc0
Read more here: ❇️ ow.ly/GIh450X2qc0
September 26, 2025 at 5:36 PM
🔎Around 1 in 4 people with CCA have chronic liver diseases, and 1 in 10 have cirrhosis.
Read more here: ❇️ ow.ly/GIh450X2qc0
Read more here: ❇️ ow.ly/GIh450X2qc0
📣This systematic review/meta-analysis yielded a coherent picture from a compositional perspective, which may help identify beneficial donor profiles and guide personalized FMT approaches. Read more here: ➡️ ow.ly/Tecs50X1uvA
September 24, 2025 at 1:32 PM
📣This systematic review/meta-analysis yielded a coherent picture from a compositional perspective, which may help identify beneficial donor profiles and guide personalized FMT approaches. Read more here: ➡️ ow.ly/Tecs50X1uvA
This model quantifies the benefits of CT for at-risk FDRs of newly identified individuals with CRC and LS ➡️Read more: ow.ly/b7c950WZ7uk
September 19, 2025 at 2:07 PM
This model quantifies the benefits of CT for at-risk FDRs of newly identified individuals with CRC and LS ➡️Read more: ow.ly/b7c950WZ7uk
These findings directly inform design of regulatory clinical trials with respect to managing concomitant medications at baseline ➡️ Read more: ow.ly/xsH650WVlVv
September 15, 2025 at 8:59 PM
These findings directly inform design of regulatory clinical trials with respect to managing concomitant medications at baseline ➡️ Read more: ow.ly/xsH650WVlVv
👩⚕️ Introducing #CGH Associate Editor, Dr. Lisa Strate! The most rewarding aspects of her role include:
1️⃣ collaborating with editors, authors, and reviewers
2️⃣ staying connected to cutting-edge science
Read her bio here: ow.ly/6Lnp50WW1c5
1️⃣ collaborating with editors, authors, and reviewers
2️⃣ staying connected to cutting-edge science
Read her bio here: ow.ly/6Lnp50WW1c5
September 15, 2025 at 8:58 PM
👩⚕️ Introducing #CGH Associate Editor, Dr. Lisa Strate! The most rewarding aspects of her role include:
1️⃣ collaborating with editors, authors, and reviewers
2️⃣ staying connected to cutting-edge science
Read her bio here: ow.ly/6Lnp50WW1c5
1️⃣ collaborating with editors, authors, and reviewers
2️⃣ staying connected to cutting-edge science
Read her bio here: ow.ly/6Lnp50WW1c5
📖 Non-invasive tests (NITs) for portal hypertension in PBC perform poorly in severe cholestasis. RESIST criteria outperform elastography-based tests for ruling out high-risk varices. Further studies needed to assess the performance of NITs in PBC-cACLD
▶️ ow.ly/JnMJ50WPRJS
▶️ ow.ly/JnMJ50WPRJS
September 12, 2025 at 6:48 PM
📖 Non-invasive tests (NITs) for portal hypertension in PBC perform poorly in severe cholestasis. RESIST criteria outperform elastography-based tests for ruling out high-risk varices. Further studies needed to assess the performance of NITs in PBC-cACLD
▶️ ow.ly/JnMJ50WPRJS
▶️ ow.ly/JnMJ50WPRJS
Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients With Decompensated #Cirrhosis ➡️ ow.ly/WeMa50WPRuC
September 10, 2025 at 8:21 PM
Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients With Decompensated #Cirrhosis ➡️ ow.ly/WeMa50WPRuC
New study by @Yujun__Wong: Alcohol cirrhosis had lower risk of mortality after acute variceal bleeding.
Cirrhosis etiology (ALD vs non-ALD) should be included in risk-stratification of AVB.
Check out why bilirubin matters in this case.
🔗 ow.ly/AjJF50WPR1h
Cirrhosis etiology (ALD vs non-ALD) should be included in risk-stratification of AVB.
Check out why bilirubin matters in this case.
🔗 ow.ly/AjJF50WPR1h
September 9, 2025 at 9:46 PM
New study by @Yujun__Wong: Alcohol cirrhosis had lower risk of mortality after acute variceal bleeding.
Cirrhosis etiology (ALD vs non-ALD) should be included in risk-stratification of AVB.
Check out why bilirubin matters in this case.
🔗 ow.ly/AjJF50WPR1h
Cirrhosis etiology (ALD vs non-ALD) should be included in risk-stratification of AVB.
Check out why bilirubin matters in this case.
🔗 ow.ly/AjJF50WPR1h
⭐ Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients: ow.ly/PWjv50WNLgu
September 5, 2025 at 7:28 PM
⭐ Worsening Disease Severity as Measured by I-SEE Associates With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis Patients: ow.ly/PWjv50WNLgu
Hypercoagulation After Hospital Discharge in Acute Severe Ulcerative #Colitis: A Prospective Study ➡️ ow.ly/gtXq50WLFlW
August 29, 2025 at 7:59 PM
Hypercoagulation After Hospital Discharge in Acute Severe Ulcerative #Colitis: A Prospective Study ➡️ ow.ly/gtXq50WLFlW
📖 #ICYMI, our September issue is live! This issue includes a review focusing on "Burden of Nonmalignant Liver and Pancreatic Diseases in the United States Population"
☑️ Read the full journal issue here: ow.ly/68oO50WLAUm
☑️ Read the full journal issue here: ow.ly/68oO50WLAUm
August 25, 2025 at 6:53 PM
📖 #ICYMI, our September issue is live! This issue includes a review focusing on "Burden of Nonmalignant Liver and Pancreatic Diseases in the United States Population"
☑️ Read the full journal issue here: ow.ly/68oO50WLAUm
☑️ Read the full journal issue here: ow.ly/68oO50WLAUm
⭐ August Images and Videos presents: An Elusive #Pancreatic Mass
🔗 Learn more here: ow.ly/snjb50WHxUN
🔗 Learn more here: ow.ly/snjb50WHxUN
August 22, 2025 at 9:47 PM
⭐ August Images and Videos presents: An Elusive #Pancreatic Mass
🔗 Learn more here: ow.ly/snjb50WHxUN
🔗 Learn more here: ow.ly/snjb50WHxUN
A Real-World Study of Cumulative Steroid Burden Among Patients With Eosinophilic #Esophagitis in the United States ➡️ ow.ly/UcsK50WHxHQ
August 20, 2025 at 4:49 PM
A Real-World Study of Cumulative Steroid Burden Among Patients With Eosinophilic #Esophagitis in the United States ➡️ ow.ly/UcsK50WHxHQ
Environmental Risk Factors for Gallbladder Cancer: Field-Wide Systematic Review and Meta-Analysis ➡️ ow.ly/1bQ350WHxju
August 18, 2025 at 5:01 PM
Environmental Risk Factors for Gallbladder Cancer: Field-Wide Systematic Review and Meta-Analysis ➡️ ow.ly/1bQ350WHxju
⭐Practice Management: The Road Ahead article examines impact of artificial intelligence on the #gastroenterology workforce and practice
Learn more here ➡️ ow.ly/wtAg50WByRc
Learn more here ➡️ ow.ly/wtAg50WByRc
August 15, 2025 at 9:23 PM
⭐Practice Management: The Road Ahead article examines impact of artificial intelligence on the #gastroenterology workforce and practice
Learn more here ➡️ ow.ly/wtAg50WByRc
Learn more here ➡️ ow.ly/wtAg50WByRc
📖 These results demonstrate that the Atmo Capsule is a valid method for evaluating gastrointestinal transit:
ow.ly/yztt50WByHv
ow.ly/yztt50WByHv
August 13, 2025 at 9:13 PM
📖 These results demonstrate that the Atmo Capsule is a valid method for evaluating gastrointestinal transit:
ow.ly/yztt50WByHv
ow.ly/yztt50WByHv
This study suggests that a diet with high TAC may help prevent the development of #IBD, particularly in individuals at high genetic risk of IBD and in mutation carriers of rs4880 in SOD2 ➡️ ow.ly/wyTk50WByvO
August 11, 2025 at 8:30 PM
This study suggests that a diet with high TAC may help prevent the development of #IBD, particularly in individuals at high genetic risk of IBD and in mutation carriers of rs4880 in SOD2 ➡️ ow.ly/wyTk50WByvO
📖 Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity
🔗 ow.ly/12aA50WyPU2
🔗 ow.ly/12aA50WyPU2
August 8, 2025 at 7:28 PM
📖 Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity
🔗 ow.ly/12aA50WyPU2
🔗 ow.ly/12aA50WyPU2
Histologic remission of MASH or significant fibrosis improves survival after bariatric surgery ➡️ ow.ly/r58N50WyPJe
August 6, 2025 at 8:59 PM
Histologic remission of MASH or significant fibrosis improves survival after bariatric surgery ➡️ ow.ly/r58N50WyPJe
A CGH #liver disease article was recently featured in the @latimes.com ▶️ ow.ly/mJa850WxGkJ
🔗 Don't miss the CGH piece here: ow.ly/4N0x50WxGkI
@amergastroassn.bsky.social
🔗 Don't miss the CGH piece here: ow.ly/4N0x50WxGkI
@amergastroassn.bsky.social
Serious liver disease is up among heavy drinkers, even without more drinking
A new study by Keck Medicine School of USC finds the incidence of alcohol-related liver disease has more than doubled, especially among women, older adults, and people with underlying health condition...
ow.ly
August 5, 2025 at 5:37 PM
A CGH #liver disease article was recently featured in the @latimes.com ▶️ ow.ly/mJa850WxGkJ
🔗 Don't miss the CGH piece here: ow.ly/4N0x50WxGkI
@amergastroassn.bsky.social
🔗 Don't miss the CGH piece here: ow.ly/4N0x50WxGkI
@amergastroassn.bsky.social
Neighborhood-level SDOH are associated with MASLD burden, comorbidities, and mortality and should be considered in clinical care, quality improvement, and further research: ow.ly/VPSt50WyPA4
August 4, 2025 at 9:32 PM
Neighborhood-level SDOH are associated with MASLD burden, comorbidities, and mortality and should be considered in clinical care, quality improvement, and further research: ow.ly/VPSt50WyPA4
📖 Validation and Epidemiologic Definition of the Novel Steatotic #Liver Disease Nomenclature in a National United States Cohort With #Cirrhosis: ow.ly/5btu50Ww7Rh
August 1, 2025 at 10:17 PM
📖 Validation and Epidemiologic Definition of the Novel Steatotic #Liver Disease Nomenclature in a National United States Cohort With #Cirrhosis: ow.ly/5btu50Ww7Rh
⭐ ESG is an effective and safe method to promote weight reduction associated with significant improvement in patients with MASH and obesity.
🔗 Learn more: ow.ly/cUp750Ww7GK
🔗 Learn more: ow.ly/cUp750Ww7GK
July 30, 2025 at 9:01 PM
⭐ ESG is an effective and safe method to promote weight reduction associated with significant improvement in patients with MASH and obesity.
🔗 Learn more: ow.ly/cUp750Ww7GK
🔗 Learn more: ow.ly/cUp750Ww7GK